Issue 216

24.09.2021

Europe
USA
Latam & Caribbean
APAC
Africa & Middle East

HIGHLIGHTS 

 

NEW YORK CANNABIS LEGALISATION A ‘PIVOTAL MOMENT’ FOR THE INDUSTRY – LEAFLY CEO

Ahead of delivering the keynote speech at Business of Cannabis: New York next week (September 29), Leafly CEO Yoko Miyashita has emphatically endorsed the legalisation of cannabis in New York as being a ‘pivotal moment’ for the North American cannabis industry.

Legalisation in New York, Miyashita says, could have profound, positive economic implications, whilst also providing a blueprint for a socially equitable, socially just and diverse cannabis industry. Importantly, the Leafly CEO believes legalisation in New York will also push federal legalisation forward.

READ MORE »

 


 

CANNABIS BANKING PROVISIONS IN THE SAFE BANKING ACT PASSED BY HOUSE OF REPRESENTATIVES

READ MORE »

 

EIHA DEMANDS HIGHER THC ALLOWANCES FOR HEMP SEED OIL AND DRY FOODS

READ MORE »

Europe

  • Spain approves its first medical cannabis-based medicine, Epidyolex, for the treatment of severe medical conditions.
  • Italy’s cannabis cultivation referendum reaches 500 thousand signatures one week after being launched.
  • Zurich prepares for cannabis study, calling for pharmacies and other interested parties to serve as cannabis clubs.
  • French hemp laws will force farmers to be contracted to industrialists, with no ability to sell to small-scale producers.
  • UK plans to launch a cannabis medicine clinical trial for drug-resistant epilepsy patients beginning at the end of 2021.
  • Luxembourg to release measures for cannabis regulation, though plans for adult-use legalisation remain unclear.
  • The majority of German political parties support removing hemp from drug law jurisdiction, to allow for further research.
  • Scotland decriminalises drug possession including cannabis, issuing warnings instead of criminal charges.
  • Apeiron Investment Group invests further in Synbiotic SE, now accounting for 45% ownership of the company.

USA

  • Amazon supports Cannabis Administration and Opportunities Act, which would legalise cannabis at a federal level.
  • The AAFCO says it requires more research into hemp animal feed before legalising it at the federal level.
  • Sen. Liz Krueger to provide details on New York’s cannabis legalisation model at Business of Cannabis: New York summit.
  • Pennsylvania senators to discuss introducing DUI protections for medical cannabis patients.
  • Patients registered with the medical cannabis programme in Connecticut to be allowed to cultivate for personal use.
  • New Hampshire to introduce constitutional amendment that would see adult-use cannabis legalised in the 2022 ballot.
  • CannaTrac Technologies prepares for a public listing on the US OTC market, the CSE and the FSE.

UPCOMING EVENT

ONLY 20 TICKETS REMAINING FOR BUSINESS OF CANNABIS: NEW YORK

There are just five days to go until the inaugural Business of Cannabis: New York summit on 29 September at the Rainbow Room, Rockefeller Center. There are just 20 tickets remaining for the exclusive event.

This is your last chance to join over 300 influential investors, policy makers and business leaders to shape the future of cannabis in New York.

BUY TICKETS »

CANADA

LATAM & CARIBBEAN

  • Brazilian councillor in Joinville proposes to regulate distribution of medical cannabis to patients.
  • The legislative assembly of São Paolo launches a parliamentary front to improve cannabis legislation in the state.
  • The Provincial Association of Medicinal Cannabis, which aims to help Argentina’s cannabis farmers, obtains legal status.
  • Colombia prepares for new cannabis regulations legalising cannabis dispensaries and cannabis stores.
  • APOTEKA finalises distribution agreement with Valens, bringing Valens’s products to Latin America and the Caribbean.
  • Flora Growth announces intention to enter into Panama’s cannabis market through its partnership with Robust Farms Inc.
  • Colombia to allow foreign investment in its cannabis industry which would see an estimated US$288 million economic gain.

CANNABIS EUROPA

AMPLIFY YOUR BRAND AT CANNABIS EUROPA LONDON – 10-11 NOVEMBER

Cannabis Europa sponsorship offers brands exposure to some of the most influential stakeholders in the international cannabis industry. Our previous events have been supported by some of the industry’s most well-known brands, including: MGC Pharmaceuticals, Aurora, DLA Piper & Curaleaf.

We have a number of different sponsorship packages available that we can discuss with you.

BECOME A SPONSOR »

APAC

AFRICA & MIDDLE EAST

  • Globe-Cann expands into South Africa to provide consulting services to cannabis companies in the region.
  • An Israeli medical cannabis association brings a petition to high court to stop medical cannabis price hikes.
  • Bophelo secures its first distribution agreement with Cantourage, bringing its products to the European market.
  • Ghanaian Court of Appeal judge supports the commercialisation of cannabis for economic gain and foreign exchange.

Read the stories that shape the cannabis industry